QF
RGNX icon

QVT Financial’s Regenxbio RGNX Stock Holding History

QVT Financial’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-193,432
Closed -$3.73M – 80
2017
Q1 		$3.73M Sell
193,432
-56,672
-23% -$1.09M 0.12% 64
2016
Q4 		$4.64M Sell
250,104
-120,839
-33% -$2.31M 0.14% 70
2016
Q3 		$5.2M Sell
370,943
-53,425
-13% -$590K 0.2% 56
2016
Q2 		$3.4M Hold
424,368
– – 0.23% 63
2016
Q1 		$4.53M Buy
424,368
+72,843
+21% +$932K 0.28% 69
2015
Q4 		$5.18M Buy
+351,525
New +$6.98M 0.29% 61

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

QVT Financial's RGNX Position: Q2 2017 in Review

QVT Financial sold out of Regenxbio (RGNX) in Q2 2017, closing a stake of 193,432 shares — an estimated $3.73M sold.

QVT Financial first reported a position in RGNX in Q4 2015 and held it in 6 quarters. The position peaked at $5.2M in Q3 2016. 86 funds tracked by Wall St. Rank hold RGNX as of Q2 2017.

  • QVT Financial reported no remaining Regenxbio position as of Q2 2017 after selling out during the quarter.
  • QVT Financial sold 193,432 Regenxbio shares in Q2 2017, an estimated $3.73M.
  • QVT Financial first reported a position in Regenxbio in Q4 2015 and held it in 6 quarters.
  • QVT Financial's Regenxbio position peaked at $5.2M in Q3 2016.
  • 86 funds tracked by Wall St. Rank held Regenxbio as of Q2 2017.

Based on QVT Financial's 13F filing for Q2 2017, filed 14 Aug 2017.